サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609868

日本の免疫組織染色市場レポート：製品、用途、エンドユーザー、地域別、2025年～2033年

Japan Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033

出版日
発行
IMARC
ページ情報
英文 117 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
日本の免疫組織染色市場レポート：製品、用途、エンドユーザー、地域別、2025年～2033年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 117 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の免疫組織染色市場の市場規模は2024年に1億7,770万米ドルに達しました。IMARC Groupは、2025年から2033年にかけての成長率（CAGR）は6.1％で、2033年には3億2,120万米ドルに達すると予測しています。加齢に関連した疾患の有病率の増加、強力なヘルスケアインフラの存在、個別化医療に対する意識の高まり、医学研究に対する政府による資金提供や支援の増加、病理学分野における最近の進歩などが、市場を牽引する主な要因となっています。

本レポートで扱う主な質問

  • 日本の免疫組織染色市場はこれまでどのように推移し、今後どのように推移していくのか？
  • 日本の免疫組織染色市場へのCOVID-19の影響は？
  • 日本の免疫組織染色市場の製品別の内訳は？
  • 日本の免疫組織染色市場の用途別の内訳は？
  • 日本の免疫組織染色市場のエンドユーザー別の内訳は？
  • 日本の免疫組織染色市場のバリューチェーンにはどのような段階がありますか？
  • 日本の免疫組織染色における主な促進要因と課題は何か？
  • 日本の免疫組織染色市場の構造と主要プレーヤーは？
  • 日本の免疫組織染色市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の免疫組織染色市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の免疫組織染色市場情勢

  • 過去および現在の市場動向（2019年～2024年）
  • 市場予測（2025-2033）

第6章 日本の免疫組織染色市場：製品別の内訳

  • 抗体
  • 装置
  • 試薬
  • キット

第7章 日本の免疫組織染色市場：用途別の内訳

  • 診断
  • 薬剤検査

第8章 日本の免疫組織染色市場：エンドユーザー別の内訳

  • 病院および診断研究所
  • 研究機関
  • その他

第9章 日本の免疫組織染色市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第10章 主要企業のプロファイル

第11章 日本の免疫組織染色市場：業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第12章 付録

目次
Product Code: SR112024A18972

Japan immunohistochemistry market size reached USD 177.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 321.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.1% during 2025-2033. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.

Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.

Japan Immunohistochemistry Market Trends:

The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.

Japan Immunohistochemistry Market Segmentation:

Product Insights:

  • Antibodies
  • Primary Antibodies
  • Secondary Antibodies
  • Equipment
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Others
  • Reagents
  • Histological Stains
  • Blocking sera and Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Stabilizers
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
  • Kits

Application Insights:

  • Diagnostics
  • Cancer
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
  • Drug Testing

End User Insights:

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan immunohistochemistry market?
  • What is the breakup of the Japan immunohistochemistry market on the basis of product?
  • What is the breakup of the Japan immunohistochemistry market on the basis of application?
  • What is the breakup of the Japan immunohistochemistry market on the basis of end user?
  • What are the various stages in the value chain of the Japan immunohistochemistry market?
  • What are the key driving factors and challenges in the Japan immunohistochemistry?
  • What is the structure of the Japan immunohistochemistry market and who are the key players?
  • What is the degree of competition in the Japan immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Immunohistochemistry Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Immunohistochemistry Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Immunohistochemistry Market - Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Primary Antibodies
      • 6.1.3.2 Secondary Antibodies
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Slide Staining Systems
      • 6.2.3.2 Tissue Microarrays
      • 6.2.3.3 Tissue Processing Systems
      • 6.2.3.4 Slide Scanners
      • 6.2.3.5 Others
    • 6.2.4 Market Forecast (2025-2033)
  • 6.3 Reagents
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Segmentation
      • 6.3.3.1 Histological Stains
      • 6.3.3.2 Blocking sera and Reagents
      • 6.3.3.3 Chromogenic Substrates
      • 6.3.3.4 Fixation Reagents
      • 6.3.3.5 Stabilizers
      • 6.3.3.6 Organic Solvents
      • 6.3.3.7 Proteolytic Enzymes
      • 6.3.3.8 Diluents
    • 6.3.4 Market Forecast (2025-2033)
  • 6.4 Kits
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)

7 Japan Immunohistochemistry Market - Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Segmentation
      • 7.1.3.1 Cancer
      • 7.1.3.2 Infectious Diseases
      • 7.1.3.3 Cardiovascular Diseases
      • 7.1.3.4 Autoimmune Diseases
      • 7.1.3.5 Diabetes Mellitus
      • 7.1.3.6 Nephrological Diseases
    • 7.1.4 Market Forecast (2025-2033)
  • 7.2 Drug Testing
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Immunohistochemistry Market - Breakup by End User

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Research Institutes
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2019-2024)
    • 8.3.2 Market Forecast (2025-2033)

9 Japan Immunohistochemistry Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Immunohistochemistry Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix